| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |